2018

Avenell, A, Bolland, M,Grey, A. 25-hydroxyvitamin D – should labs be measuring it? Ann Clin Biochem 2018. [Editorial]

Treweek, S,Littleford, R. Trial management– building the evidence base for decision-making. Trials 2018;19:11. [Editorial]

2017

Boyers, D, Hernandez, R, Sharma, P, Scott, N, Fraser, C, Cruickshank, M, Ahmed, I, Ramsay, C,Brazzelli, M. 'Primary inguinal hernia: changing open repair technique likely cost-effectiveHERU Policy Briefing 2017.

2016

Avenell, A, Bolland, M, Grey, A,Reid, IR. Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention [letter]Osteoporos Int 2016:DOI 10.1007/s00198-016-3765-6.

Bolland, M, Avenell, A,Grey, A. Qualitative research, observational research, and The BMJ [letter]BMJ 2016;352:i1483 doi: 10.136/bmj.i83.

Bolland, M, Avenell, A, Grey, A,Reid, IR. Errors in NOF meta-analyses of calcium and vitamin D supplements [letter]Osteoporosis Int 2016:DOI 10.1007/s00198-015-3466-6. 

Goulao, B, MacLennan, GM. Mindfulness-based stress reduction for veterans with PTSD [letter]JAMA 2016;315(1):87-88.

Hernandez, R. Treatment or monitoring for people with ocular hypertension? HERU Policy Briefing 2016;July.

Hernandez, R, Burr, J, Azuara-Blanco, A, Cook, JA, Banister, K, Tuulonen, A,Ryan, M. Treatment or monitoring for people with ocular hypertensionHERU Policy Briefing 2016:URL: https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_May_2016.pdf.

Kilonzo, M. Gallstones: wait and see or treat? HERU Policy Briefing 2016; April:https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_April_2016.pdf.

2015

Kilonzo, M. Reducing hospital infections: which catheter?HERU Policy Briefing 2015;December:https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_December_2015.pdf.

Morgan, HM. Will fitness trackers damage our relationships with our doctors?The Conversation 2015

Scotland, G. Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy?HERU Policy Briefing 2015;September:https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_Sept_2015.pdf.

Scotland, G,Tassie, E. Cost-effectiveness of treatments for varicose veinsHERU Policy Briefing 2015;April:https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_April_2015.pdf.

2013

Bolland MJ, Avenell A, Grey A, Reid IR. What is the appropriate MHRA regulatory response to calcium's increased cardiovascular risk? [letter] BMJ 2013;346:f3413.

Entwistle VA, Watt IS. A capabilities approach to person-centred care: response to Open Peer Commentaries on 'Treating patients as persons: a capabilities approach to support delivery of person centered care' [letter]. American Journal of Bioethics 2013;13(8):W1-W4.

Entwistle, V. A. and Cribb, A. Encouraging collaborative working with people with long-term conditions: the practical importance of ideas [blog]. Sax Institute 2013.Available from URL: https://cipher.org.au/encouraging-collaborative-working-with-people-with-long-term-conditions-the-practical-importance-of-ideas/

McCleary N, Johnston M, Francis J. Inadequate reporting of non-pharmacological interventions occurs in abstracts as well as full-text articles [rapid response]. BMJ 2013;347:F3755.

Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N'Dow J. Assessing catheter-associated urinary tract infection-Authors' reply [letter]. Lancet 2013;381(9877):1536.